Refine by
In Vitro Equipment Supplied In Australia
24 equipment items found
Manufactured by:Avania based inBrunswick, AUSTRALIA
The right in vitro diagnostic (IVD) device can streamline clinical trials and expedite personalized patient care. We deliver world-class assistance for your IVD device development. We’ll help you build out effective research studies and protocols designed to validate algorithm reliability and ...
Manufactured by:Genetic Signatures Ltd. based inNewtown, AUSTRALIA
The STI Genital Pathogen and Reproductive Health Reagents are rapid in vitro nucleic acid amplification assays for the qualitative detection of sexually transmitted pathogens as well as commensal and reproductive health-associated ...
Manufactured by:Universal Biosensors based inRowville, AUSTRALIA
PETRACKR strips are designed specifically to be used with this system for in vitro diagnostic use. Accurate when testing fresh capillary, or fresh venous whole blood samples. The PETRACKR® system is designed for ease of use and fast blood glucose results for cats and dogs with ...
Manufactured by:Genetic Signatures Ltd. based inNewtown, AUSTRALIA
The Respiratory Pathogen ASRs are rapid in vitro nucleic acid amplification tests for the qualitative detection of respiratory pathogen nucleic acid from respiratory specimens. Molecular methods offer the advantages of rapidity and the ability to detect pathogens regardless of growth requirements or the availability of reagents for rapid diagnostic testing. ...
Manufactured by:Care Essentials Pty Ltd. based inNorth Geelong, AUSTRALIA
The SARS-CoV-2 / COVID-19 Antigen Test Kit is an in vitro diagnostic rapid test used for the qualitative detection of the SARS-CoV-2 Antigen (Ag) in nasopharyngeal swab specimens from individuals with symptoms within a 7 day period. This test kit is for professional use only, by a health professional or a laboratory professional, and is intended to be used as an aid in the ...
Manufactured by:Genetic Signatures Ltd. based inNewtown, AUSTRALIA
The most common protozoans that affect the gastrointestinal tract are Cryptosporidium spp., Giardia intestinalis, and Entamoeba histolytica1-3. Other protozoan agents that have been implicated in gastroenteritis in humans include Dientamoeba fragilis, Blastocystis hominis and Cyclospora cayetanensis. ...
by:AdAlta Limited based inBundoora, AUSTRALIA
An i-body is a human protein that belongs to the class of next generation antibodies. The i-body is built on the scaffold of a human protein and engineered with two loops that mimic the shape of shark antibodies. These loops are responsible for binding or interacting with a particular target (in circulation or on a cell) that is causing disease. i-bodies are identified and developed using our ...
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Single well qPCR test for detection of Neisseria gonorrhoeae and markers linked to ciprofloxacin susceptibility validated on a range of specimens and collection vessels. Antibiotic resistance in gonorrhoea infections is a global concern. There are limited effective treatment options and novel antibiotics are not readily available. Smarter and more directed use of antibiotics can be achieved ...
Manufactured by:Bio Molecular Systems based inUpper Coomera, AUSTRALIA
The world’s first magnetic induction cycler is now a registered medical device with CE-IVD and TGA approval. Mic IVD is manufactured under an ISO 13485:2016 Quality Management System. ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Mesoblast’s proprietary mesenchymal lineage adult stem cells (MLCs) are found in multiple tissues where they play vital roles in maintaining tissue ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
VIRALEZE™ is an antiviral nasal spray that contains astodrimer sodium (SPL7013), which has been shown in laboratory studies to inactivate a broad spectrum of respiratory viruses, including >99.9% of coronavirus SARS-CoV-2, the virus that causes ...
Manufactured by:BioDiem Ltd. based inSouth Melbourne, AUSTRALIA
BDM-I: Addressing market need for next-generation antimicrobials. Infectious diseases often dominate the media headlines, including rising antibiotic resistance and fear of “super bugs”. One serious problem facing the global community is that anti-infective treatments that were once effective now cannot be relied upon. There are some strains of infections including tuberculosis, blood ...
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Single well qPCR test for detection of Mycoplasma genitalium (Mgen) and macrolide resistance markers validated on a range of specimens and collection vessels. Resistance to the macrolide treatment (Azithromycin) is of growing concern when managing M. genitalium (Mgen) infections. Guidelines around the world now call for the practice of Resistance Guided Therapy to guide appropriate treatment ...
by:Microba Life Sciences based inBrisbane City, AUSTRALIA
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has established a platform for drug discovery and development that leverages a growing, proprietary Databank of human microbiome samples and associated metadata. Precision techniques enable ...
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Detect COVID-19 causative coronavirus, SARS-CoV-2; Multiplex RT-qPCR test with dual targets (RdRp/ORF1ab) and RNA-based internal control in a single-well. Scalable solution supporting surge ...
Manufactured by:NeuroScientific Biopharmaceuticals Ltd. based inCottesloe, AUSTRALIA
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-25-Osteo for spinal fusion is a proprietary Phase 3-ready product candidate. All doses of MPC-25-Osteo for the treatment of spinal fusion consist of 25 million MPCs delivered on a collagen ceramic carrier material into the disc space with stabilizing ...
Manufactured by:LISCure Biosciences Inc. based inSeongnam-si, SOUTH KOREA
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
by:AdAlta Limited based inBundoora, AUSTRALIA
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, CXCR4 and demonstrates anti-fibrotic effects in several models of fibrosis. This was initially called AD-114. Following further development, AdAlta ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
MPC-06-ID is a Phase 3 product candidate for the treatment of chronic low back pain caused by disc degeneration (CLBP). It is being developed for patients who have exhausted conservative treatment options, may have failed epidural steroid injections and have no further treatment option other than invasive and costly surgical ...